{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:21:45Z","timestamp":1789647705565,"version":"4.0.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ahj.2013.06.009","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T08:37:05Z","timestamp":1373963825000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications"],"prefix":"10.1016","volume":"166","author":[{"given":"Pieter A.","family":"Vriesendorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend F.L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Cleemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J.L.M.","family":"Jordaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic A.M.J.","family":"Theuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomy J.","family":"de Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert J.","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.06.009_bb0005","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/01.CIR.0000034170.83171.0B","article-title":"Hypertrophic cardiomyopathy","volume":"106","author":"Maron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.009_bb0010","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJMra022783","article-title":"Sudden death in young athletes","volume":"349","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.009_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1106468","article-title":"Cardiac arrest during long-distance running races","volume":"366","author":"Kim","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.009_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.009_bb0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjcard.2004.01.057","article-title":"Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy","volume":"93","author":"Jayatilleke","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.009_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.06.009_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.009_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.06.009_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.06.009_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pcad.2008.10.001","article-title":"Risks and challenges of implantable cardioverter-defibrillators in young adults","volume":"51","author":"Sherrid","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ahj.2013.06.009_bb0055","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1460-9592.2003.00285.x","article-title":"Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"26","author":"Begley","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2013.06.009_bb0060","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.06.009_bb0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/hrt.2008.150656","article-title":"Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy","volume":"95","author":"Lin","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.06.009_bb0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.009_bb0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2013.06.009_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O'Mahony","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.06.009_bb0085","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0195-668X(03)00479-2","volume":"24","author":"Maron","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.06.009_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2013.06.009_bb0095","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1161\/CIRCULATIONAHA.106.178233","volume":"114","author":"Zipes","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.009_bb0100","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1253\/circj.CJ-10-0921","article-title":"Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"74","author":"Maron","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2013.06.009_bb0105","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehq337","article-title":"2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy","volume":"31","author":"Dickstein","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.06.009_bb0110","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.009_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1023973306742","article-title":"Is inappropriate implantable defibrillator shock therapy predictable?","volume":"8","author":"Nanthakumar","year":"2003","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.ahj.2013.06.009_bb0120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/hrt.2006.090290","article-title":"Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy","volume":"93","author":"Woo","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.06.009_bb0125","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.009_bb0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2013.06.009_bb0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2013.06.009_bb0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2013.06.009_bb0145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:50:02Z","timestamp":1757569802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313004201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002870313004201"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.06.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}